Monday, August 17, 2015 10:03:19 AM
The Food and Drug Administration's (FDA) filers (i.e., employees who are required to file either a confidential or public financial disclosure report) may not hold financial interests in companies which are significantly regulated by the FDA. For purposes of the FDA Conflict of Interest regulations and this listing, "significantly regulated" is defined as "an organization in which the sales of FDA-regulated products constitute ten percent or more of annual gross sales in the organization's previous fiscal year. Where an organization does not have a record of sales of FDA-regulated products, it will be deemed to be significantly regulated if its operations are solely in fields regulated by FDA."
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM